NuPathe to Present at the Stifel Nicolaus Healthcare Conference 2011
(firmenpresse) - CONSHOHOCKEN, PA -- (Marketwire) -- 09/01/11 -- NuPathe Inc. (NASDAQ: PATH) today announces that , chief executive officer, will present a company overview at the Stifel Nicolaus Healthcare Conference 2011 on Thursday, September 8, 2011 at 9:10 a.m. EDT. The conference is being held at the Four Seasons Hotel in Boston, MA.
A live audio webcast of the presentation will be available via the "Investor Relations" page of the NuPathe website, . Please log on through NuPathe's website approximately 10 minutes prior to the scheduled start time. A replay of the webcast will also be archived on the Company's website for 30 days following the presentation.
NuPathe Inc. () is a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, , is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two additional proprietary product candidates: for the continuous symptomatic treatment of Parkinson's disease, which the company plans to partner, and in preclinical development for the long-term treatment of schizophrenia and bipolar disorder.
John Woolford
(443) 213-0506
Keith A. Goldan
Vice President, Chief Financial Officer
NuPathe Inc.
(484) 567-0130
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.09.2011 - 20:30 Uhr
Sprache: Deutsch
News-ID 61797
Anzahl Zeichen: 0
contact information:
Town:
CONSHOHOCKEN, PA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 219 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NuPathe to Present at the Stifel Nicolaus Healthcare Conference 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
NuPathe Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
